logo

For the Inventor, By the Inventor

Basel, Switzerland

Beigene Switzerland Gmbh


USPTO Granted Patents = 22



Trademarks = 30

Forward Citations = 111

Loading Chart...
Loading Chart...

46 inventors (with patents filed for the assignee):

goldMedal Zhiwei Wang (11 out of 63 patents)

silverMedal Yunhang Guo (11 out of 23 patents)

bronzeMedal Gongyin Shi (8 out of 8 patents)

4.  Tong Zhang (7 out of 87 patents)

5.  Kang Li (7 out of 32 patents)

6.  Jing Song (6 out of 15 patents)

7.  Qi Liu (5 out of 100 patents)

8.  Lai Wang (5 out of 8 patents)

9.  Hao Peng (4 out of 11 patents)

10.  Lanlan Xu (4 out of 7 patents)

11.  Min Wei (3 out of 14 patents)

12.  Jason Paik (3 out of 3 patents)

13.  Ying Ou (3 out of 3 patents)

14.  Tommi Salmi (3 out of 3 patents)

15.  Lusong Luo (2 out of 4 patents)


22 patents:

1. 12234286 - Anti-TIGIT antibodies and their use as therapeutics and diagnostics (2025-02-25),
2. 12233069 - Oral solid tablet comprising Bruton's Tyrosine Kinase inhibitor and preparation method therefor (2025-02-25),
3. 12103931 - Crystalline form of (S)-7-(1-acryloylpiperidin-4-yl)-2-(4-phenoxyphenyl)-4,5,6,7-tetra-hydropyrazolo[1,5-a]pyrimidine-3-carboxamide, preparation, and uses thereof (2024-10-01),
4. 11999743 - Crystalline form of (S)-7-(1-acryloylpiperidin-4-yl)-2-(4-phenoxyphenyl)-4,5,6,7-tetra-hydropyrazolo[1,5-a]pyrimidine-3-carboxamide, preparation, and uses thereof (2024-06-04),
5. 11970500 - Crystalline form of (s)-7-(1-acryloylpiperidin-4-yl)- 2-(4-phenoxyphenyl)-4,5,6,7-tetra- hydropyrazolo[1,5-a]pyrimidine-3-carboxamide, preparation, and uses thereof (2024-04-30),
6. 11911386 - Methods of treating B-cell proliferative disorder (2024-02-27),
7. 11896596 - Methods of treating B-cell proliferative disorder (2024-02-13),
8. 11884674 - Crystalline form of (S)-7-(1-acryloylpiperidin-4-yl)-2-(4-phenoxyphenyl)-4,5,6,7-tetra- hydropyrazolo[1,5-a]pyrimidine-3-carboxamide, preparation, and uses thereof (2024-01-30),
9. 11851437 - Crystalline form of (S)-7-(1-acryloylpiperidin-4-yl)-2-(4-phenoxyphenyl)-4,5,6,7-tetra-hydropyrazolo[1,5-a]pyrimidine-3-carboxamide, preparation, and uses thereof (2023-12-26),
10. 11814389 - Crystalline form of (S)-7-(1-acryloylpiperidin-4-yl)-2-(4-phenoxyphenyl)-4,5,6,7-tetra-hydropyrazolo[1,5-a]pyrimidine-3-carboxamide, preparation, and uses thereof (2023-11-14),
11. 11786531 - Methods of treating B-cell proliferative disorder (2023-10-17),
12. 11786529 - Treatment of indolent or aggressive B-cell lymphomas using a combination comprising BTK inhibitors (2023-10-17),
13. 11701357 - Treatment of B cell cancers using a combination comprising Btk inhibitors (2023-07-18),
14. 11673951 - Anti-PD1 antibodies and their use as therapeutics and diagnostics (2023-06-13),
15. 11591340 - Crystalline form of (S)-7-(1-acryloylpiperidin-4-yl)-2-(4-phenoxyphenyl)-4,5,6,7-tetra- hydropyrazolo[1,5-a]pyrimidine-3-carboxamide, preparation, and uses thereof (2023-02-28),
Beigene Switzerland Gmbh is a biotechnology company focused on discovering, developing, and commercializing innovative medicines to improve the lives of cancer patients worldwide. The company's mission is to become a global leader in oncology and take a leading position in the biopharmaceutical industry.
This text is generated by artificial intelligence and may not be accurate.

logo

Company Badge

USPTO Data Jan 1 1976 - Dec 9 2025

22 Patents

#21 in Basel

#547 in Switzerland

#27,863 in the World

...
Basel, Switzerland

Beigene Switzerland Gmbh

Forward Citations = 111

46 inventors:

goldMedal Zhiwei Wang (11 out of 63 patents)

silverMedal Yunhang Guo (11 out of 23 patents)

bronzeMedal Gongyin Shi (8 out of 8 patents)

4.  Tong Zhang (7 out of 87 patents)

5.  Kang Li (7 out of 32 patents)

Please report any incorrect information to support@idiyas.com
Loading…